Funding
Seed · Healthtech

iPremom raises €15m seed for prenatal risk assessment

Amadeus Capital Partners and Asabys co-led financing for validation, commercial rollout and regulatory work.

Updated Oct 16, 2026By RoundOS Funding desk

iPremom raised €15 million in seed financing led by Amadeus Capital Partners and co-led by Asabys Partners through Sabadell Asabys II. APEX Ventures participated.

The company will complete clinical validation, roll out MaiRa commercially and advance European and U.S. regulatory approvals. MaiRa is available in Spain under prescription and estimates preeclampsia risk from a maternal blood sample collected in early pregnancy.

Use of funds

Complete clinical validation of the MaiRa platform

Commercially roll out MaiRa

Advance regulatory approvals in the European Union and United States

Funding history

Seed · This round€15M

Sources

  1. iPremom raises €15m to transform pregnancy care with molecular diagnosticsamadeuscapital.com · Sep 2, 2026
  2. Addressing complicated pregnancies, iPremom raises €15 million to advance early detectioneu-startups.com · Sep 2, 2026
  3. ipremom.com
  4. ipremom.com

Similar rounds

All Healthtech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
SEGNOS

SEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing.

UndisclosedPre-Series A · Oct 22, 2026
CureBay

CureBay operates a hybrid healthcare network for rural and underserved communities in India.

~₹1BPre-Series C · Oct 22, 2026
iCUREX

Kagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.

¥140MSeries A first close: equity and debt · Oct 22, 2026

Related